Research Topics
| Maureen MeadeSummaryAffiliation: McMaster University Country: Canada Publications
| Collaborators
|
Detail Information
Publications
The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for cliniciansCaterina Mannucci
Department of Medicine, McMaster University and St. Joseph's Healthcare, Hamilton, Ontario, Canada
Intern Emerg Med 1:96-104. 2006....
Initial and long-term treatment of deep venous thrombosis: recent clinical trials and their impact on patient managementAaron Liew
McMaster University, Department of Medicine, St Joseph s Healthcare, F 544, 50 Charlton Ave East, Hamilton, ON, L8N 4A6, Canada 905 521 6178 905 521 6068
Expert Opin Pharmacother 14:385-96. 2013....
Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II studyJames D Douketis
Dept of Medicine, McMaster University, Hamilton, ON, Canada
Thromb Res 130:381-9. 2012..This test has an anatomic component to locate DVT and a functional component to differentiate acute (newly formed) thrombus from inactive (old) thrombus...
The effect of prothrombotic blood abnormalities on risk of deep vein thrombosis in users of hormone replacement therapy: a prospective case-control studyJim D Douketis
Department of Medicine, McMaster University, Hamilton, Canada
Clin Appl Thromb Hemost 17:E106-13. 2011..Few studies have assessed the effect of prothrombotic blood abnormalities on the risk of deep vein thrombosis (DVT) with hormone replacement therapy (HRT)...
Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practiceJ D Douketis
Department of Medicine, McMaster University, Hamilton, Canada
Int J Obes (Lond) 29:1153-67. 2005....
Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysisJames Douketis
St Joseph s Healthcare Hamilton, Hamilton, ON, Canada
BMJ 342:d813. 2011..Data source Comprehensive search of electronic databases (Medline, Embase, CINAHL, Cochrane Central Register of Controlled Trials) until July 2010, supplemented by review of conference abstracts and contact with content experts...
Dabigatran as anticoagulant therapy for atrial fibrillation. Which patients should receive it, which patients may not need it, and other practical aspects of patient managementJames D Douketis
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Pol Arch Med Wewn 121:73-80. 2011..within the context of how the quality of anticoagulation control affects warfarin efficacy and safety; and 3) to consider which patients with chronic atrial fibrillation should receive and which may not need to receive dabigatran...
Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control studyJ D Douketis
Department of Medicine, McMaster University, Hamilton, Canada
J Thromb Haemost 3:943-8. 2005..Although hormone replacement therapy (HRT) is associated with an increased risk of deep vein thrombosis (DVT), it is not clear if the risk differs in users of combined estrogen-progestin HRT and estrogen-only HRT...
Combination warfarin-ASA therapy: which patients should receive it, which patients should not, and why?James D Douketis
Department of Medicine, McMaster University and St Joseph s Healthcare, Hamilton, ON, Canada
Thromb Res 127:513-7. 2011....
Treatment of deep vein thrombosis: what factors determine appropriate treatment?James D Douketis
Department of Medicine, McMaster University, Hamilton, Ont
Can Fam Physician 51:217-23. 2005..To identify patients with deep vein thrombosis (DVT) for whom in-hospital treatment should be considered...
The incidence and prognostic significance of elevated cardiac troponins in patients with submassive pulmonary embolismJ D Douketis
Department of Medicine, McMaster University, Hamilton, Canada
J Thromb Haemost 3:508-13. 2005..1; 95% CI: 0.2-4.9). In patients who present with submassive PE, an elevated cTnI occurs in about one in seven patients and is associated with a 3.5-fold increased risk of all-cause death...
Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgeryJames D Douketis
Department of Medicine and St Joseph s Heathcare, McMaster University, Hamilton, Canada
Thromb Haemost 94:528-31. 2005..In patients who require bridging anticoagulation with LMWH, a residual anticoagulant effect from LMWH is detected in 1 of 6 patients, and receiving therapeutic-dose LMWH is the strongest predictor of such an effect...
Prophylaxis against venous thromboembolism in hospitalized medical patients: an evidence-based and practical approachJames D Douketis
Department of Medicine, McMaster University and St Joseph s Healthcare, Hamilton, ON, Canada
Pol Arch Med Wewn 118:209-15. 2008..Additional research is needed to develop a validated risk stratification model for hospitalized medical patients that can help identify patients who would benefit most from anticoagulant prophylaxis...
Hormone replacement therapy and risk for venous thromboembolism: what's new and how do these findings influence clinical practice?James Douketis
Department of Medicine, McMaster University and St Joseph s Hospital, Hamilton, Ontario, Canada
Curr Opin Hematol 12:395-400. 2005..hormone replacement therapy? Does the presence of thrombophilia influence the risk for venous thromboembolism in hormone replacement therapy users? Should hormone replacement therapy be temporarily interrupted around the time of surgery?..
Perioperative management of antithrombotic therapyJames D Douketis
Department of Medicine, McMaster University and St Joseph s Healthcare, Hamilton, ON, Canada
Pol Arch Med Wewn 118:201-8. 2008..The overall objective of this review is to provide a practical approach relating to perioperative anticoagulation which can be used in everyday clinical practice...
Prevention of venous thromboembolism in hospitalized medical patients: addressing some practical questionsJames D Douketis
Department of Medicine, McMaster University and St Joseph s Healthcare, Hamilton, Ontario, Canada
Curr Opin Pulm Med 14:381-8. 2008....
Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT studyJames Douketis
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Arch Intern Med 168:1805-12. 2008..To challenge this premise, we evaluated if deep vein thrombosis (DVT) prophylaxis with dalteparin sodium confers an excessive anticoagulant effect in critically ill patients with severe renal insufficiency...
The long-term risk of cancer in patients with a first episode of venous thromboembolismJ D Douketis
Department of Medicine, McMaster University, Hamilton, ON, Canada
J Thromb Haemost 7:546-51. 2009..In patients with venous thromboembolism (VTE), 15-20% will have prevalent cancer when VTE is diagnosed but little is known about such patients' long-term risk, time course and predictors of new cancer...
The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolismJames D Douketis
McMaster University, Hamilton, Ontario, Canada
Ann Intern Med 147:766-74. 2007..The long-term risk for fatal pulmonary embolism (PE) after treatment of venous thromboembolism (VTE) may be an important factor in the decision to discontinue this treatment...
Does statin therapy decrease the risk for bleeding in patients who are receiving warfarin?James D Douketis
Department of Medicine, McMaster University and St Joseph s Healthcare, Hamilton, Ontario, Canada
Am J Med 120:369.e9-369.e14. 2007..Recent observations in patients with atrial fibrillation who are receiving warfarin suggest that concomitant treatment with a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin) decreases the risk for bleeding...
Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleedingJames D Douketis
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Arch Intern Med 166:853-9. 2006..Ximelagatran is a novel direct thrombin inhibitor that can be administered as a fixed oral dose, without the need for anticoagulant monitoring...
Anticoagulant prophylaxis in special populations with an indwelling epidural catheter or renal insufficiencyJames D Douketis
Department of Medicine, McMaster University, Hamilton, Ontario, Canada L8N 4A6
J Crit Care 20:324-9. 2005..This review focuses on anticoagulant prophylaxis in such patients, including reasonable approaches for using low-molecular-weight heparins as thromboprophylaxis...
Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolismJames Douketis
McMaster University, Hamilton, Ontario, Canada
Ann Intern Med 153:523-31. 2010..However, questions remain about the utility of measuring d-dimer in clinical practice...
Perioperative management of patients receiving anticoagulant or antiplatelet therapy: a clinician-oriented and practical approachJames D Douketis
St Joseph s Healthcare Hamilton, Hamilton, ON, Canada
Hosp Pract (Minneap) 39:41-54. 2011..The objective of this article is to provide an evidence-based but practical approach relating to these 2 key issues in a manner than can be applied to everyday clinical practice...
Anticoagulant effect at the time of epidural catheter removal in patients receiving twice-daily or once-daily low-molecular-weight heparin and continuous epidural analgesia after orthopedic surgeryJames D Douketis
Department of Medicine, McMaster University and St Joseph s Hospital, Hamilton, Canada
Thromb Haemost 88:37-40. 2002....
Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for cliniciansJames D Douketis
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Thromb Res 108:3-13. 2002..The objectives of this review are to focus on practical issues relating to perioperative anticoagulation and the implementation of a perioperative anticoagulation management approach that can be used in everyday clinical practice...
Pharmacologic properties of the new oral anticoagulants: a clinician-oriented review with a focus on perioperative managementJames D Douketis
Department of Medicine, McMaster University, St Joseph s Healthcare, 50 Charlton Avenue East, Hamilton, Ontario, Canada
Curr Pharm Des 16:3436-41. 2010....
Patient self-monitoring of oral anticoagulant therapy: potential benefits and implications for clinical practiceJ D Douketis
Department of Medicine, McMaster University, and St Joseph s Hospital, Hamilton, Ontario, Canada
Am J Cardiovasc Drugs 1:245-51. 2001..Additionally, self-monitoring is limited to patients who have the cognitive and physical capabilities to perform the technique required for the portable coagulometer...
Elevated cardiac troponin levels in patients with submassive pulmonary embolismJames D Douketis
Department of Medicine, McMaster University, Hamilton, Ontario, Canada L8N 4A6
Arch Intern Med 162:79-81. 2002..We performed a prospective cohort study to determine the prevalence of elevated cardiac troponin I (cTnI) levels in patients with submassive pulmonary embolism...
The management of hypertension in the overweight and obese patient: is weight reduction sufficient?James D Douketis
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Drugs 64:795-803. 2004..Additional studies are needed to determine the long-term (>1 year) efficacy and safety of antihypertensive and anti-obesity management strategies in the overweight and obese hypertensive patient...
Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomesJames D Douketis
Department of Medicine, McMaster University, and St Joseph s Hospital, Hamilton, Ontario, Canada L8N 4A6
Arch Intern Med 162:1465-71. 2002....
Prognosis in pulmonary embolismJ D Douketis
Department of Medicine, St Joseph s Hospital, McMaster University, 50 Charlton Avenue East, Hamilton, Ontario L8N 4A6, Canada
Curr Opin Pulm Med 7:354-9. 2001....
Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimenJames D Douketis
Department of Medicine, McMaster University, and Hamilton Health Sciences, General Hospital, Hamilton, Ontario, Canada
Arch Intern Med 164:1319-26. 2004..We investigated the efficacy and safety of a standardized periprocedural anticoagulation regimen with low-molecular-weight heparin...
Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factorsDeborah Cook
Department of Medicine, 1200 Main Street, McMaster University, Hamilton, Canada
Crit Care 12:R32. 2008..The objective of the present study was to evaluate the prevalence, incidence and predictors of DVT and the incidence of bleeding in intensive care unit (ICU) patients with estimated creatinine clearance <30 ml/min...
Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factorsDeborah Cook
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Crit Care Med 33:1565-71. 2005..Further research is needed to evaluate the risks and benefits of more intense venous thromboembolism prophylaxis...
PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis planDeborah Cook
Department of Medicine, McMaster University, Hamilton, Ontario, Canada L8N 3Z5
J Crit Care 26:223.e1-9. 2011....
The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patientsMark Andrew Crowther
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
J Crit Care 25:287-93. 2010..The 4Ts score (Thrombocytopenia, Timing of thrombocytopenia, Thrombosis, and oTher reason) might identify individual patients at risk of having this disorder...
Clinically important deep vein thrombosis in the intensive care unit: a survey of intensivistsDeborah Cook
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Crit Care 8:R145-52. 2004..The objective of the present survey is to identify the patient factors and radiologic features of lower limb DVT that intensivists consider more or less likely to make a DVT clinically important in ICU patients...
Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot studyDeborah J Cook
Department of Medicine, McMaster University, Hamilton, Ontario, Canada L8N 3Z5
J Crit Care 20:364-72. 2005..Its additional goals were to evaluate the suitability of the exclusion criteria and to document the range of research activities that precede accrual of patients into a trial to plan multisite management...
Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician surveyJ D Douketis
St Joseph s Hospital, McMaster University, Hamilton, Canada
Can J Cardiol 16:326-30. 2000..To survey physicians' anticoagulation preferences in patients with chronic atrial fibrillation who are undergoing elective surgery...
Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgeryJ D Douketis
Department of Medicine, St Joseph s Hospital, Hamilton, Ontario, Canada
Chest 116:1240-6. 1999....
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trialAlexander G G Turpie
McMaster University, Hamilton, Ontario L8L 2X2, Canada
Lancet 373:1673-80. 2009..We aimed to test the efficacy and safety of oral rivaroxaban for the prevention of venous thromboembolism after total knee arthroplasty...
The effects of hormone replacement therapy on thrombin generation, fibrinolysis inhibition, and resistance to activated protein C: prospective cohort study and review of literatureJ D Douketis
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Thromb Res 99:25-34. 2000....
Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapyJ D Douketis
St Joseph s Hospital, Room F 538, 50 Charlton Ave E, Hamilton, Ontario, Canada L8N 4A6
Arch Intern Med 160:3431-6. 2000....
Dabigatran versus warfarin in patients with atrial fibrillationStuart J Connolly
Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada
N Engl J Med 361:1139-51. 2009..Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases the risk of hemorrhage and is difficult to use. Dabigatran is a new oral direct thrombin inhibitor...
Anticoagulation therapy in patients with prosthetic heart valvesJames D Douketis
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Clin Adv Hematol Oncol 5:436-8. 2007
Combined warfarin-aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?Marco P Donadini
Department of Medicine, McMaster University and St Joseph s Healthcare, Hamilton, ON, L8N 4A6, Canada
J Thromb Thrombolysis 29:208-13. 2010....
Red blood cell transfusion and increased length of storage are not associated with deep vein thrombosis in medical and surgical critically ill patients: a prospective observational cohort studyChristina Katsios
Department of Medicine, McMaster University, 1200 Main Street West, Hamilton, ON L8S 4L8, Canada
Crit Care 15:R263. 2011..The objective of this study was to determine if RBC transfusions or RBC storage age predicts incident DVT in medical or surgical intensive care unit (ICU) patients...
Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: a meta-analysis of randomized controlled trialsFrancois Lamontagne
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
J Crit Care 25:420-35. 2010..We sought to determine whether systemic corticosteroids reduce hospital mortality from these illnesses...
Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysisN S Lloyd
Department of Medicine, McMaster University, and St Joseph s Healthcare, Hamilton, ON, Canada
J Thromb Haemost 6:405-14. 2008..We conducted a systematic review to determine whether anticoagulant prophylaxis reduces the risk of asymptomatic DVT compared to no prophylaxis in at-risk hospitalized medical patients...
Irbesartan in patients with atrial fibrillationSalim Yusuf
Population Health Research Institute, McMaster University, Hamilton, ON, Canada
N Engl J Med 364:928-38. 2011..The risk of cardiovascular events among patients with atrial fibrillation is high. We evaluated whether irbesartan, an angiotensin-receptor blocker, would reduce this risk...
Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysisLori-Ann Linkins
McMaster University, Hamilton, Ontario, Canada
Ann Intern Med 139:893-900. 2003....
Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trialsFrancesco Dentali
Department of Medicine, McMaster University, and St Joseph s Healthcare, Hamilton, Ontario, Canada
Arch Intern Med 167:117-24. 2007..We performed a systematic review and meta-analysis of randomized controlled trials comparing these 2 treatment strategies (combined aspirin-OAC therapy vs OAC therapy alone) to assess the therapeutic benefits and risks...
Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trialKaren Woods
Department of Medicine, McMaster University, Room F-541, 50 Charlton Avenue East, Hamilton, ON, Canada L8N 4A6
Thromb Res 114:161-5. 2004..001). DISCUSSION: Our findings support the routine use of capillary blood testing, using a portable monitor, for the management of patients in outpatient anticoagulation clinics...
Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patientsFrancesco Dentali
McMaster University and St Joseph s Healthcare, Hamilton, Ontario, Canada
Ann Intern Med 146:278-88. 2007..Underutilization of anticoagulant prophylaxis may be due to lack of evidence that prophylaxis prevents clinically important outcomes in hospitalized medical patients at risk for venous thromboembolism...
Research ethics board approval for an international thromboprophylaxis trialKristina Lutz
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada
J Crit Care 27:225-31. 2012..The objectives of this study were to examine the time from submission to approval, to analyze predictors of approval time, and to describe the scope of conditions from REBs evaluating an international thromboprophylaxis trial...
Semiquantitative dipyridamole myocardial stress perfusion imaging for cardiac risk assessment before noncardiac vascular surgery: a meta-analysisEdward Etchells
Division of General Internal Medicine at Sunnybrook and Women s College Health Sciences Centre, Toronto, Ontario, Canada
J Vasc Surg 36:534-40. 2002..Semiquantitative dipyridamole myocardial perfusion scintigraphy may provide better estimates of perioperative cardiac risk than nonquantitative scintigraphy...
Treatment of warfarin-associated coagulopathy: a physician surveyS E Wilson
St. Joseph's Hospital, Hamilton, Ontario, Canada
Chest 120:1972-6. 2001..These findings highlight the need for randomized controlled trials to compare the efficacy of different routes of administration of vitamin K for warfarin-associated coagulopathy...
The effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosusJ D Douketis
Department of Medicine, McMaster University, Hamilton, Canada
Thromb Haemost 82:1028-32. 1999..0 to 2.5, is effective in suppressing coagulation activation, and therefore, might be effective in preventing thromboembolism...
Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?J D Douketis
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Am J Med 110:515-9. 2001..To determine if the location of deep vein thrombosis is a predictor of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy...
A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequencyL R Dolovich
Centre for Evaluation of Medicines, Department of Pharmacy, St Joseph s Hospital, Hamilton, Ontario, Canada
Arch Intern Med 160:181-8. 2000....
The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)James D Douketis
McMaster University, Hamilton, Ontario, Canada
Chest 133:299S-339S. 2008....
Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarinKaren Woods
Department of Medicine, McMaster University and St Joseph s Healthcare, Room F 544, 50 Charlton Ave East, Hamilton, ON, Canada L8N 4A6
J Thromb Thrombolysis 24:93-7. 2007..In patients who require warfarin interruption before surgery and have an elevated international normalized ratio (INR) before surgery, low-dose vitamin K may normalize the INR in time for surgery...
Obesity and cardiovascular disease: pathogenic mechanisms and potential benefits of weight reductionJames D Douketis
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Semin Vasc Med 5:25-33. 2005....
Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxisD Cook
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
J Crit Care 24:168-75. 2009....
Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guideE Jamula
Department of Medicine, McMaster University, Hamilton, ON, Canada
J Thromb Haemost 6:1615-21. 2008..The perioperative management of anticoagulation in patients who are having implantation of a pacemaker or implantable cardioverter defibrillator (ICD) is a common clinical problem in which best clinical practise is not established...
Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity. Canadian Task Force on Preventive Health CareJ D Douketis
CMAJ 160:513-25. 1999....
Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trialMark A Crowther
St Joseph s Hospital, 50 Charlton Avenue East, Hamilton, Ontario L8N 4A6, Canada
Ann Intern Med 137:251-4. 2002..Excessive anticoagulation due to warfarin use is associated with hemorrhage. Subcutaneously administered vitamin K has not been evaluated for the treatment of warfarin-associated coagulopathy, yet it is widely used...
Systematic overview of warfarin and its drug and food interactionsAnne M Holbrook
Centre for Evaluation of Medicines, St Joseph s Healthcare, Hamilton, Ontario
Arch Intern Med 165:1095-106. 2005..Drug and food interactions are frequently cited as causes of adverse events with warfarin. We provide an updated systematic overview of the quality, clinical effect, and importance of these reported interactions...
Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism StudyFrederick A Spencer
Department of Medicine, McMaster University, Faculty of Health Sciences and Blood Institute, Hamilton, ON, Canada
Arch Intern Med 168:425-30. 2008..The purpose of this study was to measure and compare clinical characteristics and outcomes of patients with validated symptomatic PE and isolated DVT in a New England community...
A framework for resolving disagreement during end of life care in the critical care unitKaren Choong
Department of Pediatrics and Critical Care, McMaster Children s Hospital, McMaster University, Hamilton, Ontario
Clin Invest Med 33:E240-53. 2010..Such disagreements can cause tension and moral distress among families and clinicians...
Weaning critically ill adults from invasive mechanical ventilation: a national surveyKaren E A Burns
Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada
Can J Anaesth 56:567-76. 2009..To determine the stated practices of clinicians in weaning critically ill adults from invasive ventilation...
Does celecoxib potentiate the anticoagulant effect of warfarin? A randomized, double-blind, controlled trialFrancesco Dentali
Department of Medicine, McMaster University, Hamilton, ON, Canada
Ann Pharmacother 40:1241-7. 2006..Cyclooxygenase-2 selective NSAIDs such as celecoxib may be less likely to promote gastrointestinal bleeding; however, there are concerns that they could potentiate the anticoagulation effect of warfarin...
Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysisAdeela Nematullah
University of Toronto, Ontario, Canada
J Can Dent Assoc 75:41. 2009..To evaluate the effect of continuing warfarin therapy on the bleeding risk of patients undergoing elective dental surgical procedures...
Low-molecular-weight heparins for the treatment of acute coronary syndrome and venous thromboembolism in patients with chronic renal insufficiencyWendy Lim
Department of Medicine, McMaster University and St. Joseph's Hospital, 50 Charlton Avenue East, Hamilton, Ontario, Canada L8N 4A6
Thromb Res 118:409-16. 2006....
Safety of uninterrupted anticoagulation in patients requiring elective coronary angiography with or without percutaneous coronary intervention: a systematic review and metaanalysisErin Jamula
Department of Medicine, McMaster University and St Joseph s Healthcare, Hamilton, ON, Canada
Chest 138:840-7. 2010..However, it may be possible to safely perform some procedures, such as coronary angiography with or without percutaneous coronary intervention (PCI), without VKA interruption...
Comparison of pain and ecchymosis with low-molecular-weight heparin vs. unfractionated heparin in patients requiring bridging anticoagulation after warfarin interruption: a randomized trialErin Jamula
Department of Medicine, McMaster University, Hamilton, Canada
J Thromb Thrombolysis 28:266-8. 2009..Although LMWH and UFH are self-administered by >90% of patients, factors that may be important to patients such as differences in pain and ecchymosis have not been explored...
Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolismMadeleine Verhovsek
McMaster University and St Joseph s Hospital, Hamilton, Ontario, Canada
Ann Intern Med 149:481-90, W94. 2008..Methods for predicting risk for recurrence may identify low-risk patients who are less likely to benefit from prolonged anticoagulation...
Dosing practices and risk factors for bleeding in patients receiving enoxaparin for the treatment of an acute coronary syndromeChristine Macie
Department of Medicine, McMaster University, Hamilton, ON, Canada
Chest 125:1616-21. 2004..Coadministered clopidogrel, other drugs that affect hemostasis, and increasing age conferred an increased bleeding risk...
Management of hypertension in overweight and obese patients: a practical guide for cliniciansFrancesco Dentali
St. Joseph's Hospital, Room F-541, 50 Charlton Avenue East, Hamilton, Ontario, Canada L8N 4A6
Curr Hypertens Rep 7:330-6. 2005..Additional studies to further clarify the management of these patients are warranted...
Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysisMatthias Briel
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
JAMA 303:865-73. 2010....
Are brand-name and generic warfarin interchangeable? Multiple n-of-1 randomized, crossover trialsJennifer A Pereira
Centre for Evaluation of Medicines, St Joseph s Healthcare, Hamilton, Ontario, Canada
Ann Pharmacother 39:1188-93. 2005..Warfarin is a commonly used anticoagulant in North America. Several generic formulations have been approved, raising concern over the safety and efficacy of these products compared with brand-name Coumadin...
Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physiciansJennifer A Pereira
Centre for Evaluation of Medicines, St Joseph s Healthcare, Hamilton, ON
Can J Clin Pharmacol 12:e229-39. 2005..The issue of therapeutic equivalence has been a source of controversy in Canada since the approval of generic warfarin products in 2000...
Canadian guidelines for body weight classification in adults: application in clinical practice to screen for overweight and obesity and to assess disease riskJames D Douketis
St. Joseph's Hospital and Department of Medicine, McMaster University, Hamilton, Ont
CMAJ 172:995-8. 2005
Safety of continuing warfarin therapy during cataract surgery: a systematic review and meta-analysisErin Jamula
Department of Medicine, McMaster University and St Joseph s Healthcare, Hamilton, ON, Canada
Thromb Res 124:292-9. 2009..In patients who are receiving warfarin therapy and require cataract surgery, it may be possible to continue warfarin in the perioperative period but the safety of this management strategy has not been systematically evaluated...
Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumoniaDaren K Heyland
Kingston General Hospital and Queen s University, Kingston, ON, Canada
Crit Care Med 36:737-44. 2008..To compare a strategy of combination therapy with a strategy of monotherapy with broad-spectrum antibiotics for suspected late ventilator-associated pneumonia...
Acute renal vein thrombosis, oral contraceptive use, and hyperhomocysteinemiaH H Chan
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Mayo Clin Proc 76:212-4. 2001..In oral contraceptive users who develop venous thrombosis in the absence of other risk factors, clinicians should consider investigations for an underlying prothrombotic biochemical disorder...
Incidence of Smith-Lemli-Opitz syndrome in Canada: results of three-year population surveillanceMałgorzata J M Nowaczyk
Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada
J Pediatr 145:530-5. 2004..SLOS is a treatable genetic condition that may be difficult to diagnose in its mildest form because of nonspecific clinical markers (two- to three-toe webbing, short upturned nose, and micrognathia)...
Periprocedural anticoagulation practices in warfarin-treated patients who require elective angiography with or without percutaneous coronary intervention: a retrospective chart reviewErin Jamula
Department of Medicine, McMaster University and St Joseph s Healthcare, Hamilton ON, Canada
Thromb Res 125:351-2. 2010..However, before further high quality research can be performed in this area, information such as current practice and associated event rates is required...
Influence of warfarin on symptoms of fatigue: findings of a randomized trialMichael J Kovacs
Department of Medicine, University of Western Ontario, London, Ontario, Canada
Ann Pharmacother 39:840-2. 2005..Some patients develop fatigue while taking warfarin, but causality is uncertain...
Prevention and treatment of hormone-associated venous thromboembolism: a patient management approachJoanna Ueng
Department of Medicine, St Joseph s Healthcare Hamilton, McMaster University, Hamilton, ON, Canada
Hematol Oncol Clin North Am 24:683-94, vii-viii. 2010....
DHCR7 mutation carrier rates and prevalence of the RSH/Smith-Lemli-Opitz syndrome: where are the patients?Małgorzata J M Nowaczyk
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada
Am J Med Genet A 140:2057-62. 2006..In order to reconcile the above-mentioned paradoxes, we propose a model based on a higher than observed carrier frequency of the most common mutation and on very high fetal loss of homozygotes for that mutation...
Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarinMark A Crowther
Haematologica 90:137-9. 2005..Larger studies will be required to determine if the use of oral vitamin K, for example in patients who are temporarily discontinuing warfarin to undergo interventional procedures, is safe and effective...
2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]David C W Lau
Department of Medicine, Julia McFarlane Diabetes Research Centre, Diabetes and Endocrine Research Group, University of Calgary, Calgary, Alta
CMAJ 176:S1-13. 2007
Body weight classificationJames D Douketis
CMAJ 172:1274-5; author reply 1275. 2005
Perioperative management of warfarin therapy: to bridge or not to bridge, that is the questionJames D Douketis
Mayo Clin Proc 83:628-9. 2008
Use of a clinical prediction score in patients with suspected deep venous thrombosis: two steps forward, one step back?James D Douketis
Ann Intern Med 143:140-2. 2005
Are heparins anti-neoplastic agents?James D Douketis
Pol Arch Med Wewn 117:491-3. 2007
Why A-level evidence does not make it to clinicians' A-lists: the case of thromboprophylaxis in medical patientsJames D Douketis
ACP J Club 149:2. 2008
